Oilatum Emollient 63.4% w/w Bath Additive

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

Liquid paraffin light

Disponible desde:

GlaxoSmithKline Consumer Healthcare (Ireland) Limited

Código ATC:

D02AC

Designación común internacional (DCI):

Liquid paraffin light

Dosis:

63.4 percent weight/weight

formulario farmacéutico:

Bath additive

tipo de receta:

Product not subject to medical prescription

Área terapéutica:

Soft paraffin and fat products

Estado de Autorización:

Marketed

Fecha de autorización:

1984-10-01

Información para el usuario

Page 1 of 3

Page 2 of 3

Page 3 of 3


Ficha técnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Oilatum Emollient 63.4% w/w Bath Additive
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Light Liquid Paraffin 63.4 % w/w.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Bath additive
Pale yellow oily liquid bath additive with a faint perfume.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Oilatum Emollient is indicated in the treatment of contact dermatitis,
atopic dermatitis, senile pruritis, ichthyosis and
related dry skin conditions.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Oilatum Emollient should always be used with water, either added to
the water or applied to wet skin.
Adult Bath
Add 1-3 capfuls to an 8-inch (20cm) bath of water. Soak for 10-20
minutes. Pat dry.
Infant Bath
Add 1/2-2 capfuls to a small bath of water. Apply gently over entire
body with a sponge. Pat dry.
Skin Cleansing
Rub a small amount into wet skin, rinse off and pat dry.
Where conditions permit, and particularly in cases of extensive areas
of dry skin, Oilatum Emollient should be used as
a bath oil, ensuring complete coverage by immersion.
In addition to the therapeutic benefits, this method of use provides a
means of sedating tense patients, particularly
relevant in cases of acute pruritic dermatoses where relaxation of
tension appears to relieve symptoms.
4.3 CONTRAINDICATIONS
Known hypersensitivity to the ingredients.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_5_
_C_
_R